onsdag 23 oktober 2013

Stem Cell IPO Fate Therapeutics - Nanalyze

Stem Cell IPO Fate TherapeuticsNanalyzeFate Therapeutics focuses on the discovery and development of adult stem cell modulators alter the course of rare life-threatening diseases, sometimes known as orphan diseases. They have developed two separate platforms, which focus on activation and read more

http://blog.zandcell.com/stem-cell-ipo-fate-therapeutics-nanalyze/?utm_source=rss&utm_medium=rss&utm_campaign=stem-cell-ipo-fate-therapeutics-nanalyze

Inga kommentarer:

Skicka en kommentar